How to motivate my patient to be adherent

My first guest is Professor Richard Gale, Consultant Medical Ophthalmologist, and the Clinical Director at the York Teaching Hospital NHS Foundation Trust, UK. In this episode, we discuss the latest publications and strategies that are employed to support patients in continuing to attend appointments and receive treatment. I have included below the links to the publications that we discuss during this podcast.Okada M, et al. Ophthalmology. 2021;128(2):234-47Okada M, et al. JAMA Ophthalmol. 2021;139(7):769-76Speaker disclosures: Professor Anat LoewensteinConsultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurion, Pres-By, Roche, Sensor, WebMD, Xbrane  Professor Richard Gale: Consultancy, Research Grants: Alimera, Allergan, Bayer, Novartis, RocheJune 2025 | MA-PFM-OPHT-ALL-1190-1This podcast series is intended for HCPs, and is not intended for UK audiences. Always refer to local treatment guidelines and relevant prescribing information. Please review the product information before prescribing.This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise.The Barometer Program is managed by clinical leaders in ophthalmology as well as representatives from the IFA, IAPB and Bayer. The activities of the Barometer Program are funded and facilitated by Bayer where the scientists and representatives from IFA and IAPB retain decision authority to the research scope, methods, analysis of findings, and dissemination of the outputs of the Barometer Program.The Vision Academy is a group of over 80 international experts who, through their collective expertise, provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence. The Vision Academy is funded and facilitated by Bayer. The opinions and guidance of the Vision Academy outputs are those of its members and do not necessarily reflect the opinions of Bayer.